San Diego medical device maker NuVasive Inc. met Wall Street’s expectations in the first quarter with revenue up 16 percent to $250 million.

That revenue is only slightly below the $251 million that investors were expecting to see. Adjusted net income rose 16 percent as well, to $20 million, which worked out to $0.38 per share (exactly matching analyst expectations).

NuVasive’s financial performance has been steadily on the rise, with 2016 being a record year for the company’s revenue. NuVasive brought in $962.1 million in 2016, up 18.6 percent from 2015.